Complete response to sotorasib as neoadjuvant treatment in patient with locally advanced primary pulmonary sarcoma harboring KRAS mutation: a case report

BACKGROUND: Primary pulmonary sarcoma (PPS) is very rare relative to other subtypes of lung cancer. Therefore, evidence-based treatment options for PPS patients have remained unclear. Identification of actionable cancer driver mutations in patients with non-small cell lung cancer (NSCLC) has provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ce, Wang, Yanan, Yu, Yongyang, Li, Wei, Guo, Tao, Li, Yongle, Li, Hefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652552/
https://www.ncbi.nlm.nih.gov/pubmed/36388799
http://dx.doi.org/10.21037/atm-22-4248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652552/
https://www.ncbi.nlm.nih.gov/pubmed/36388799
http://dx.doi.org/10.21037/atm-22-4248

Ejemplares similares